Skip to main content
All lobbying filings

REVVITY, INC.

Lobbying for REVVITY, INC.

 Filing 2nd Quarter - Report
2nd Quarter (Apr 1 - June 30) 2025 · Massachusetts · House · Senate · $30,000.00 expenses · posted Apr 24, 2025

Official filing document

 Bills named in this filing 1
 Lobbying activity 2
Health Issues

Diagnostic test reimbursement and policies Genomic sequencing T-Cell Immune Response Testing Proposals related to newborn screening Proposals related to pandemic preparedness FDA Medical Device Product policies H.R. 2810, Family Cord Blood Banking Act

Trade (domestic/foreign)

Medical Device & Pharmaceutical Adjacent Tariff

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem